Orthofix Medical Inc. financial data

Symbol
OFIX on Nasdaq
Location
3451 Plano Parkway, Lewisville, TX
Fiscal year end
December 23
Latest financial report
10-Q - Q2 2025 - Aug 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 258 % +0.62%
Quick Ratio 119 % -14.7%
Debt-to-equity 75.9 % +37.2%
Return On Equity -25.4 % -23%
Return On Assets -14.5 % -8.56%
Operating Margin -11.8 % +6.36%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.5M shares +3.46%
Common Stock, Shares, Outstanding 39.5M shares +3.8%
Entity Public Float 504M USD -24%
Common Stock, Value, Issued 3.95M USD +3.79%
Weighted Average Number of Shares Outstanding, Basic 39.5M shares +3.9%
Weighted Average Number of Shares Outstanding, Diluted 39.5M shares +3.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 809M USD +4.84%
Research and Development Expense 71.8M USD -4.32%
Selling and Marketing Expense 395M USD +13.6%
General and Administrative Expense 134M USD -1.37%
Operating Income (Loss) -95.3M USD +1.81%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -123M USD -4.02%
Income Tax Expense (Benefit) 1.01M USD -60.3%
Net Income (Loss) Attributable to Parent -124M USD -2.67%
Earnings Per Share, Basic -3 USD/shares -0.32%
Earnings Per Share, Diluted -3 USD/shares -0.32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 65.6M USD +149%
Accounts Receivable, after Allowance for Credit Loss, Current 130M USD +3.35%
Inventory, Net 173M USD -17.6%
Assets, Current 396M USD +2.53%
Deferred Income Tax Assets, Net 1.54M USD -25.9%
Property, Plant and Equipment, Net 129M USD -16.2%
Operating Lease, Right-of-Use Asset 24.9M USD +33.8%
Intangible Assets, Net (Excluding Goodwill) 78.9M USD -27.2%
Goodwill 195M USD 0%
Other Assets, Noncurrent 38.3M USD -0.66%
Assets 837M USD -5.08%
Accounts Payable, Current 45.1M USD -10.5%
Employee-related Liabilities, Current 43.9M USD +13.1%
Accrued Liabilities, Current 11.4M USD -6.55%
Liabilities, Current 148M USD -4.86%
Deferred Income Tax Liabilities, Net 5.64M USD +35.2%
Operating Lease, Liability, Noncurrent 26.4M USD +68%
Other Liabilities, Noncurrent 55.9M USD +15.2%
Liabilities 379M USD +12.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 908K USD
Retained Earnings (Accumulated Deficit) -343M USD -56.3%
Stockholders' Equity Attributable to Parent 458M USD -16.1%
Liabilities and Equity 837M USD -5.08%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.4M USD +1.1%
Net Cash Provided by (Used in) Financing Activities -651K USD -103%
Net Cash Provided by (Used in) Investing Activities -6.74M USD +38%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 39.5M shares +3.8%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -25.3M USD -205%
Deferred Tax Assets, Valuation Allowance 229M USD +14.3%
Deferred Tax Assets, Gross 239M USD +11.8%
Operating Lease, Liability 18.1M USD -12.1%
Payments to Acquire Property, Plant, and Equipment 10.5M USD -8.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -120M USD +2.48%
Lessee, Operating Lease, Liability, to be Paid 22.4M USD -14.5%
Property, Plant and Equipment, Gross 352M USD +1.25%
Operating Lease, Liability, Current 3.05M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.01M USD +4.55%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.19M USD +6.67%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 445K USD +9.07%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.33M USD -23.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.65M USD -20.8%
Unrecognized Tax Benefits 1.7M USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.84M USD -46.5%
Operating Lease, Payments 2.37M USD +9.67%
Depreciation, Depletion and Amortization 82.5M USD +47.4%
Deferred Tax Assets, Net of Valuation Allowance 10.7M USD -23.7%
Share-based Payment Arrangement, Expense 28M USD -0.75%